Key Insights

Highlights

Treatment Research

7 treatments under study, led by Dexamethasone

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04265534Phase 2Terminated

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Showing all 1 trials

Research Network

Common Treatments

  • Dexamethasone1
  • Carboplatin1
  • Folic Acid 400 1000 Μg1
  • Pembrolizumab1
  • Pemetrexed1

Active Sponsors

  • Calithera Biosciences, Inc1

Top Investigators

Related Conditions

  • Nfe2l2 Gene Mutation1
  • Nonsmall Cell Lung Cancer1
  • Nonsquamous Nonsmallcell Lung Cancer1
  • Nonsquamous Nonsmall Cell Neoplasm Of Lung1
  • Keap1 Gene Mutation1

Activity Timeline